JAZZ vs PYPL · P/E 1988, rev $4.07B vs P/E 7.9, rev $33.17B
Jazz Pharmaceuticals PLC (JAZZ) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the JAZZ and PYPL stock pages for the full models.
Not investment advice.